DeepthiS,NarayanAR, 2015.Levels of serum calcium alkaline phosphatase and urinary hydroxyproline in post menopausal women,WJ Pharm Pharmaceutical Sci 4 919 -22
WheaterG,ElshahalyM,TuckSP,DattaHK,van LaarJM., 2013.The clinical utility of bone marker measurements in osteoporosis,J Transl Med 11 201 -
NaeemST,HussainR,RaheemA,SiddiquiI,GhaniF,KhanAH, 2016.Bone turnover markers for osteoporosis status assessment at baseline in postmenopausal Pakistani females,J Coll Physicians Surg Pak 26 408 -12
WaheedK,KhanumA,ButtA,EjazS,Obstet, 2016.Quality of Life after Menopause in Pakistani Women, 6 10003 -0932
AkhtarA,ShahidA,JamalAR,NaveedMA,AzizZ,BarkatN, 2016.Knowledge about osteoporosis in women of child bearing age (15-49 years) attending fauji foundation hospital Rawalpindi,Pak Armed Forces Med J 66 558 -63
KhoslaS. Minireview:, 2001.The opg/rankl/rank system,Endocrinology 142 5050 -5
ManolagasSC, 2000.Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis 1, 21 115 -37
DaiZ,WangR,AngLW,YuanJM,KohWP, 2016.Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population,Bone 83 171 -7
PisaniP,RennaMD,ConversanoF,CasciaroE,Di PaolaM,QuartaE, 2016.Major osteoporotic fragility fractures: Risk factor updates and societal impact,World J Orthop 7 171 -81
GhaziM,MounachA,NouijaiA,GhozlaniI,BennaniL,AchemlalL, 2007.Performance of the osteoporosis risk assessment tool in Moroccan men,J Clin Rheumatol 26 2037 -41
2011.Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards,Osteoporos Int 22 391 -420
VasikaranS,EastellR,BruyèreO,FoldesA,GarneroP,GriesmacherA, .Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards,Osteoporos Intl 201 391 -420
MukaiyamaK,KamimuraM,UchiyamaS,IkegamiS,NakamuraY,Kato H, 2015.Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover,Aging Clin Exp Res 27 413 -8
2011.ar ers of bone turnover for the prediction of fracture ris and monitoring of osteoporosis treatment need for international reference standard,s Osteoporos Int 22 391 -420
BhattaraiT,BhattacharyaK,ChaudhuriP,SenguptaP, 2014.Correlation of common biochemical markers for bone turnover, serum calcium, and alkaline phosphatase in post-menopausal women,The Malaysian journal of medical sciences: MJMS 21 58 -
MarinL,KoivulaMK,Jukkola-VuorinenA,LeinoA,RisteliJ, 2011.Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases,Ann Clin Biochem 48 447 -51
JagtapVR,GanuJV, 2011.Serum osteocalcin: A specific marker for bone formation in postmenopausal osteoporosis,Bone 2 5 -
JagtapVR,GanuJV,NaganeNS, 2011.BMD and serum intact osteocalcin in postmenopausal osteoporosis women,Indian J Clin Biochem 26 70 -3
SinghS,KumarD,LalAK, 2015.Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women,J Clin Diagn Res 9 RC04 -
BrownJP,AlbertC,NassarBA,AdachiJD,ColeD,DavisonKS, 2009.Bone turnover markers in the management of postmenopausal osteoporosis,Clin Biochem 42 929 -42
JungK,LeinM,StephanC,Von HösslinK,SemjonowA,SinhaP, 2004.Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications,Int J Cancer 111 783 -91
StokesFJ,IvanovP,BaileyLM,FraserWD, 2011.The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism,Clin Chem 57 138 -40
HassagerC,JensenS,GotfredsenA,ChristiansenC., 1991.The impact of measurement errors on the diagnostic value of bone mass measurements: theoretical considerations,Osteoporos Int 1 250 -6
MillerPD, 2012.Bone strength and surrogate markers: the first, second, and third fiddle,J Bone Miner Res 27 1623 -6
BjarnasonN,HenriksenE,AlexandersenP,ChristgauS,HenriksenD,ChristiansenC, 2002.Mechanism of circadian variation in bone resorption,Bone 30 307 -13
BaxterI,RogersA,EastellR,PeelN., 2013.Evaluation of urinary Ntelopeptide of type I collagen measurements in the management of osteoporosis in clinical practice,Osteoporos Int 24 941 -7
MelkkoJ,HellevikT,RisteliL,RisteliJ,SmedsrødB, 1994.Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells,Int J Clin Exp Med 179 405 -12
EastellR,KregeJH,ChenP,GlassEV,ReginsterJY, 2006.Development of an algorithm for using PINP to monitor treatment of patients with teriparatide,Curr Med Res Opin 22 61 -6
TerreniA,PezzatiP, 2012.Biochemical markers in the follow-up of the osteoporotic patients,Clin Cases Miner Bone Metab 9 80 -4
ChenP,SatterwhiteJH,LicataAA,LewieckiEM,SiposAA,MisurskiDM, 2005.Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis,J Bone Miner Res 20 962 -70
NaylorK,EastellR, 2012.Bone turnover markers: use in osteoporosis,Nat Rev Rheumatol 8 379 -89
RenisM,LobreglioD,CongedoP,MontinaroMC,MuratoreM,LobreglioG, 2018.Assessment of serum vitamin B12 levels and other metabolic parameters in subjects with different values of bone mineral density,J Clin Med Res 10 233 -
NomuraY,YoshizakiA,YoshikataH,KikuchiR,SakakibaraH,ChakiO, 2013.Study of the distribution by age group of serum cross-linked C-terminal telopeptide of type I collagen and procollagen type I N-propeptide in healthy Japanese women to establish reference values,J Bone Miner Metab 31 644 -51
ZhaoJ,XiaW,NieM,ZhengX,WangQ,WangX, 2011.The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study,Menopause 18 1237 -43
KharroubiA,SabaE,SmoomR,BaderK,DarwishH.,Serum, 2017.- hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women,Arch Osteoporos 12 13 -
ScarianoJ,GlewR,Bou-SerhalC,ClemensJ,GarryP,BaumgartnerR, 1998.Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women,Bone 23 471 -7
LiuSZ,TianLF,XuP,ZhuangGH,ZhengF,TianJ, 2011.Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women,Curr Mol Biol Rep 38 939 -48
HuWW,ZhangZ,HeJW,FuWZ,WangC,ZhangH, 2013.Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women,Int J Endocrinol 513925 -
Kuču, 2013.The utility of procollagen t pe1 N-terminal propeptide for the bone status assessment in postmenopausal wome,nBosn J Basic Med Sci 13 259 -
GaoC,QiaoJ,LiS,YuW,HeJ,FuW, 2017.The levels of bone turnover markers 25 (OH) D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China,Osteoporos Intl 28 211 -8